Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 2.1mg equivalent to 12.5mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 4.2mg equivalent to 25mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 6.3mg equivalent to 37.5mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 8.4mg equivalent to 50mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 12.6mg equivalent to 75mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Product: Fentanyl Sandoz
Active Ingredient: Fentanyl 16.8mg equivalent to 100mcg/hr
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Hexal AG, Holzkirchen, Germany
Dated this 21st day of March 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).